• Ankylosing Spondylitis
• Systemic Lupus Erythematosus
• Some Others
• Localized autoimmune disease diagnostics
• Multiple Sclerosis
• Type 1 diabetes
• Hashimoto’s thyroiditis
• Idiopathic Thrombocytopenic purpura
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/autoimmune-disease-diagnostics-market-
419
The technological advancements in the North America region driving the autoimmune disease
diagnostics market
The regional segmentation of autoimmune disease diagnostics market by Coherent Market
Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North
America is of the largest revenue contributor in the global autoimmune disease diagnostics
industry. This is mainly attributed to rising incidence of some of the common autoimmune
diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government
and private sector, increasing regulatory scenario monitored by World Health Organization
(WHO), and technological advancements are some of the factors which are driving growth of
the autoimmune disease diagnostics market in the North America region. Asia Pacific is
projected to be a fast emerging region in the global autoimmune disease diagnostic market.
The introduction of novel biomarkers in the market will aid in the growth of autoimmune
disease diagnostic market
The key players operating the autoimmune disease diagnostics market are Abbott Laboratories,
Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics,
Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and
many others. The government agencies of various countries are increasing their healthcare
spending to provide better health care services, and the introduction of novel biomarkers in the
research area, owing for ample opportunity for the key players, which in-turn will boost the
autoimmune diseases diagnostic market.